BEAM vs FOXA · rev $63.5M vs P/E 14, $24.50B cap
Beam Therapeutics Inc (BEAM) versus Fox Corp Class A (FOXA) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
FOXA does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B. FOXA currently screens at market cap $24.50B and trailing P/E 14.1.
Not investment advice. Open the BEAM and FOXA stock pages for the full models.
Not investment advice.